About Us - Evans Baroque

Evans Baroque (EB) is a world-class pharmaceutical and healthcare products company with broad West African (Sub-Saharan African) reach and global partnerships. The company owns, formulates, manufactures, markets, and distributes a combination of both owned and licensed products in Nigeria and Sierra Leone.

Dedicated to its vision of HEALTHY AFRICA leveraging on Research, local content, global partnerships, speed to market.

Evolution

2012

Operations Begin in Sierra Leone

Evans Baroque (then Miral Pharm. Limited) commenced operations in Sierra Leone, implementing a nationwide distribution network across every major city. Over 100 products registered, with an additional 20 in the registration pipeline.

2013

Nigeria Operations Launch

Following the successful Sierra Leone model, EB entered the Nigerian market. Today, with over 80 products across public health and specialised disease segments, the Nigerian operation is central to EB's West African expansion strategy.

2018

Acquisition of Evans Medical Plc Manufacturing Assets

A landmark milestone. Miral Pharm Ltd acquired the manufacturing assets of Evans Medical Plc (formerly Glaxo) in the Agbara Industrial Estate — 8.3 hectares. This facility is one of only four pharmaceutical plants in Nigeria prequalified by the World Health Organization (WHO).

2019

Rebranding: Miral Pharm Becomes Evans Baroque Ltd.

Miral Pharm Ltd formally became Evans Baroque Ltd — marking a bold new chapter and broader vision: to serve Africa with world-class healthcare standards wrapped in warmth, humanity, and deep community connection.

Now

A Growing West African Healthcare Leader

Evans Baroque aggressively expands across multiple therapeutic segments — managed by professionals with demonstrable excellence across the healthcare value chain.